ABSTRACT
Objective: To investigate the drug-related information needs of healthcare providers (HCPs), their utilization of drug information resources as well as the main factors influencing the selection of resources. Methods: A total of 393 HCPs were conveniently selected and invited to complete a questionnaire. Stratified sampling was used for the three subpopulations of physicians, pharmacists, and nurses. The questionnaire was coded, validated, and analyzed using the Statistical Package for the Social Sciences (SAS version 9.2). Results: Of 450 HCPs approached, 393 completed the questionnaire (response rate 87%). Information related to drug dosage/administration, indications, and interactions is the most frequently required, 47%, 44%, and 34%, respectively. The majority of the sample perceived the Internet (69.47%) and electronic databases (67.43%) as “very useful.” Printed materials (46.56%) and Personal Digital Assistants (PDAs) (44.78%) or calling the pharmacy (43.26%) were also useful resources of information followed by using electronic books and journals (38.42%) and asking colleagues (32.32%). The majority (53.18%) described consulting a clinical pharmacist as “very useful.” However, 16% of the nurse group and 35% of the physician group were not aware of the existence of the Drug Information Center (DIC) and more than 8% of the participants consider calling the DIC about drug-related information “not useful”. Conclusion: Digital resources are used by HCPs more frequently than traditional resources, consulting a clinical pharmacist or calling the DIC. Providing reliable electronic resources and raising the awareness of HCPs regarding the role of a clinical pharmacist and DIC for patient-specific therapies should be instituted.
ABSTRACT
Objective: Since January 2013, the national drug information center (NDIC) has started providing services and since December 2013, it is answering all the public and professional inquiries made through the Ministry of Health (MOH)-Hotline Calling Services (937). Therefore, in this study, we explored the cost avoidance analysis of national drug information inquiries by the hotline services in Saudi Arabia. Methods: We simulated the drug information inquiries related to the adults and children for the duration of 12 months of 2014 through MOH-hotline calling services (937). At least 10 on-call clinical pharmacists and expert trained pharmacists were receiving calls made from public and professionals inquiring about drug information. The data were collected in the drug information data collecting form through manual documentation system of drug information inquiries. Results: The drug information pharmacist implicated that the high-cost avoidance at the public side came from the dose standardization (30,310 USD (37.5%)) of the total cost avoidance followed by the drug administration and adverse drug reaction (16,532 USD (20.45%) and 9,347.5 USD (11.56%), respectively), which represent more than 50% of the total cost avoidance from the public side. With regard to professional inquiries, the drug information pharmacist implicated that the highest cost avoidance was through inquiries related to drugs in pregnancy, which was around 7,527.50 USD (26%) of the total cost followed by the drug administration, drug–drug interaction and drug identification (4,792 USD (16.5%); 4,141.50 USD (14.3%); and 4,135.50 USD (14.2%), respectively), which represent more than 50% of the total cost avoidance from the professional side. Conclusion: NDIC was the first in calculating cost avoidance from answering drug information inquiries from professional and public separately in the Middle Eastern countries. It is highly implicated in the drug information services in the healthcare organization in the Kingdom of Saudi Arabia.
ABSTRACT
Drug Information Centers (DIC) have an important place in the health care process since they provide independent and updated information. A search was developed in Medline, Science Direct, Academic Search Complete, LILACS and Academic Google in order to know the state of the art of DIC around the world. Regarding to a timeline, the first European DIC was created in 1960 and studies that described local situation were identified in 1996 and 2001. Thereafter, in the United States the first DIC was created in 1962 and 3 studies that describe DIC characteristics and changes trough time were identified between 2003 and 2008. Moreover, DICs were created in Singapore in 1980 and in Venezuela in 1981. In India was created a DIC in 1997. Subsequently, the WHO performed workshops in 2006 in order to create new centers in this country. In Asia was conducted a study in 1996 that identified 4 DIC. Concerning Latin America were found studies that describe local DIC from Brazil (2001) and Costa Rica (2003). Also, the network of Latin American and Caribbean DICs (REDCIMLAC) was created in 2011. In all consulted studies the DICs features were described including type of questions, professionals and infrastructure among others. Some of these studies included a comparison with the WHO technical document.
Los Centros de Información de Medicamentos (CIM) ocupan un lugar importante en el proceso de atención en salud al proporcionar información independiente y actualizada. Con el fin de conocer el estado del arte de los CIMs alrededor del mundo, se desarrolló una búsqueda en las bases de datos Medline, Science Direct, Academic Search Complete, LILACS y en Google Académico. Revisando cronológicamente la creación de CIMs, se encontró que el primero fue fundado en Europa en 1960. Posteriormente, se crearon en Estados Unidos en 1962, Singapur, 1980 y Venezuela, 1981. En India se fundó un CIM en 1997, posteriormente la OMS dictó talleres en ese país para fortalecer la creación de nuevos CIMs en 2006. En Asia se realizó un estudio en 1996 que identificó cuatro CIMs. En cuanto a Latinoamérica, se encontraron estudios de Brasil (2001) y Costa Rica (2003) que describen los CIMs locales. Adicionalmente, en 2011, se creó la red de CIMs de Latinoamérica y el Caribe (REDCIMLAC). En todos los estudios consultados se identificaron características de funcionamiento de los CIMs, como infraestructura, tipo de consultas, personal, entre otras. Algunos de estos estudios incluyeron una comparación con el documento técnico de la OMS.
ABSTRACT
OBJETIVO: evaluar los recursos de información disponibles en el Centro de Estudio, Documentación e Información de Medicamentos (CEDIMED). MÉTODOS: se identificaron aquellas fuentes, servicios y sistemas que pudieran llegar a alcanzar la categoría de entidad o recurso de información dentro del CEDIMED, empleando la metodología INFOMAP. Se recolectaron datos sobre el costo de los recursos identificados y se desarrolló un ordenamiento de estos según su característica. Se determinó el índice de valor para cada ERIs y se elaboraron las matrices de usuario, gerente y suministradores, lo que posibilitó conocer el rol de cada miembro de la organización con respecto a los recursos de información. Se analizó la variable fondos de información, en la que se estudiaron un total de 15 indicadores. RESULTADOS: se identificaron 47 entidades o recursos de información disponibles en el centro; de estas 36 internas y 11 externas. Los fondos documentales con los que cuenta el CEDIMED no presentaron un alto grado de actualización; sin embargo, las temáticas contenidas en estos, resultaron altamente pertinentes a las funciones de este tipo de organización. Alrededor de la mitad de los indicadores analizados fue evaluado de excelente; sin embargo, la variable fondos de información fue regular. CONCLUSIONES: todo centro o servicio de información sobre medicamentos debe contar con recursos de información de calidad y fácil acceso por los usuarios; así como establecer una política para el desarrollo de los fondos y la realización de estudios sobre el uso de las diversas colecciones disponibles en la institución(AU)
OBJECTIVE: to evaluate the information resources available at the Center of Study, Documentation and Information on Drugs (CEDIMED). METHODS: identification of those sources, services and systems that might attain the category of entity or of information resource within CEDIMED by using the INFOMAD methodology. Data on the cost of identified resources were collected and ordered according to their characteristics. The value index was determined for each ERI and the user, manager and supplier matrices were prepared, all of which made it possible to know the role of each member of the organization in relation to the information resources. The variable called information stocks was analyzed including the study of 15 indicators. RESULTS: forty seven information entities or resources were available at the center, 36 domestic and 11 external. The documentary stocks of CEDIMED were not highly updated; however, their topics were highly relevant for the functions of this type of organization. The evaluation of almost half of the analyzed indicators was excellent but the variable information stocks were rated as regular. CONCLUSIONS: every information center or service on drugs should have quality easy-to-access resources for users and should also set a policy aimed at developing the stocks and at carrying out studies on the use of the various collections located in the institution(AU)
Subject(s)
Humans , Drug Information Services , Information Centers , Management Audit/standardsABSTRACT
Introdução: o Centro de Informações sobre Medicamentos (CIM) busca, através de suas fontes de pesquisa, identificar as possíveis interações medicamentosas que possam prejudicar ou não o paciente no momento da administração. Objetivo: descrever as interações medicamentosas identificadas pelo CIM, a partir de solicitações dos profissionais internos de hospital universitário. Método: foi realizado estudo descritivo, no período de janeiro de 2009 a maio de 2011, das solicitações relacionadas com interações medicamento x medicamento, medicamento x alimentos e sondas enterais e incompatibilidades medicamentosas. Das solicitações, verificou-se a disponibilidade de informação na literatura e a orientação fornecida ao solicitante. Resultados: das solicitações de interações medicamentosas, envolvendo 55 medicamentos, foram informadas 19 interações, na sua maioria moderadas (61%) e de efeito tardio (50%). Das interações medicamento x alimentos (N=15), 26,7% apresentaram efeitos de alteração na farmacocinética dos medicamentos. Para interações envolvendo medicamentos e dietas enterais, 58,3% dos fármacos não apresentavam interação, 25% não foram testados com dietas enterais e 16,7% foram considerados contraindicados. Em relação às incompatibilidades medicamentosas, dos medicamentos solicitados, 52,8% foram compatíveis e 16,1%, incompatíveis. Conclusão: o CIM vem auxiliando na resolução de dúvidas, mas a indisponibilidade de informações na literatura nem sempre permite uma prática segura e correta no momento da administração dos medicamentos.
Introduction: based on research of the literature, the Drug Information Center is aimed at identifying possible drug interactions that may harm patients. Aim: to describe the profile of drug interactions identified by the Drug Information Centre according to the information requested by the staff of a university hospital. Method: a descriptive study was conducted from January 2009 to May 2011. We reviewed the requests related to interactions of drug vs. drug, drug vs. food, and enteral tube and drug incompatibilities. In relation to the information requests, we also investigated the availability of information in the literature and the instructions provided to the requester. Results: among the requests involving 55 drugs, there were 19 drug interactions. Most of them were moderate (61%) and had late effect (50%). Among the drug vs. food interactions (n=15), 26.7% showed changes in the pharmacokinetics of drugs. In terms of interactions involving drugs and enteral feeding, 58.3% of the drugs did not show any interactions, 25% were not tested with enteral feeding, and 16.7% were considered contraindicated. With regard to drug incompatibility, 52.8% of the requests were compatible and 16.1% were incompatible. Conclusion: the Drug Information Center has been useful to assist in the resolution of doubts, but the unavailability of information in the literature not always enables a correct and safe practice of drug administration.
Subject(s)
Humans , Male , Female , Drug Incompatibility , Drug Interactions , Enteral Nutrition/adverse effects , Epidemiology, DescriptiveABSTRACT
Objetivo: descrever as atividades do Centro de Informações sobre Medicamentos do Hospital de Clínicas de Porto Alegre (CIM-HCPA), no período de 2007 a 2010. Resultados: a média de solicitações passivas, no período, foi de 1160/ano e de informação ativa, de 160/ano. O programa de Farmacovigilância recebeu 1340 notificações de reações adversas a medicamentos e 155 notificações de produtos com problemas. A literatura disponível é atualizada e compatível conforme as recomendações. Na pesquisa de satisfação, 43% dos usuários classificaram o trabalho como ótimo. Conclusão: o CIM-HCPA vem cumprindo seus objetivos, fornecendo informação objetiva, atualizada e oportuna sobre medicamentos para os profissionais da instituição
Aim: to describe the activities of the Drug Information Center of Hospital de Clínicas de Porto Alegre (DIC-HCPA) from 2007 to 2010. Results: the mean of passive requests was 1160/year and of active information was 160/year. The Pharmacovigilance Program received 1340 notifications of adverse drug reactions and 155 notifications of products with problems. The bibliographic resources are updated and in agreement with recommendations. The results of a satisfaction survey indicated that 43% of the users classified the activities as excellent. Conclusion: the DIC-HCPA has been meeting its aim of providing objective, updated and timely information on drugs to professionals from the institution
Subject(s)
MedicineABSTRACT
Objetivo: O objetivo deste trabalho foi descrever as atividades passivas realizadas por um Centro de Informações sobre Medicamentos (CIM) de hospital universitário no sul do Brasil. Resultados: de 2002 a 2008, o total de solicitações recebidas foi de 8035, das quais 30,3% foram realizadas por enfermeiros, 24,3% por farmacêuticos e 15% por técnicos de enfermagem. O tempo gasto para a resposta foi em 56,8% das vezes de até 10 minutos. Os temas mais solicitados foram administração de medicamentos (25,6%), identificação do produto (16,4%), posologia (10,6%) e estabilidade (9,6%). Conclusão: O CIM é uma estratégia na busca pelo uso seguro e racional de medicamentos nos hospitais.
Aim: The aim of this study was to describe the passive activities of Drug Information Center (DIC) of a university hospital in southern Brazil. Results: From 2002 to 2008, the total of requests was 8035, of which 30.3% were answered by nurses, 24.3% pharmacists and 15% technical nursing. The time spent to response was less than 10 minutes in 56.8%. The principal requests were about drug administration (25.6%), identification of the product (16.4%), dosage (10.6%) and stability (9.6%). Conclusion: The DIC is a strategy in the search for safe and rational use of drugs in hospitals.